Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Greenwich LifeSciences, Inc. (GLSI)

Greenwich LifeSciences dismisses auditor RBSM, hires MaloneBailey for 2025 audit

Neutral Impact 3 of 5 other Written later

Greenwich LifeSciences, Inc. dismissed RBSM LLP as its independent registered public accounting firm and engaged MaloneBailey LLP to audit its financial statements for the year ending December 31, 2025. RBSM's reports on the 2024 and 2023 financial statements contained no adverse opinion, disclaimer, or qualification, and the filing states there were no disagreements with RBSM. The filing notes material weaknesses in internal control over financial reporting disclosed in prior 10-K and 10-Q reports, which shareholders may want to monitor under the new auditor.

Key points

  • Audit committee approved the change on July 19, 2025; RBSM was informed it would be dismissed effective immediately.
  • RBSM's audit reports for fiscal 2024 and 2023 had no adverse opinion, disclaimer, or qualification.
  • The company cites material weaknesses in internal control over financial reporting in its 2024 and 2023 10-K reports and its 2024 and March 31, 2025 10-Q reports.
  • RBSM's letter to the SEC, dated July 22, 2025, is filed as Exhibit 16.1.

The filing

CompanyGreenwich LifeSciences, Inc. (GLSI)
Form8-K, current report
Filed with the SECJul 24, 2025, 4:30 PM ET
Accession number0001641172-25-020843

Items reported: 4.01 Auditor Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 24, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.